|
End-of-day quote
Buenos Aires S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 1,585.00 ARS | +1.60% |
|
+0.96% | -19.75% |
| Market Cap | 13TCr 8.49Cr 7.31Cr 6.88Cr 6.28Cr 12Cr 801.83Cr 12Cr 81Cr 32Cr 411.39Cr 32Cr 31Cr 1.33TCr | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 36TCr 24Cr 20Cr 19Cr 18Cr 33Cr 2.25TCr 33Cr 227.91Cr 88Cr 1.15TCr 89Cr 88Cr 3.72TCr | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | +1.60% | ||
| 1 week | +0.96% | ||
| Current month | -1.55% | ||
| 1 month | +3.26% | ||
| 3 months | -2.76% | ||
| 6 months | +1.60% | ||
| Current year | -19.75% |
| 1 week | 1,530 | 1,615 | |
| 1 month | 1,495 | 1,615 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.60% | +0.96% | +38.43% | +176.13% | 8.49Cr | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,02400Cr | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 66TCr | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 45TCr | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 35TCr | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 30TCr | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 25TCr | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 24TCr | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 21TCr | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 19TCr | ||
| Average | -0.68% | +0.83% | +29.63% | +64.71% | 36.78TCr | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.18TCr 6.09Cr 5.24Cr 4.93Cr 4.5Cr 8.43Cr 575.07Cr 8.45Cr 58Cr 23Cr 295.05Cr 23Cr 22Cr 950.51Cr | 13TCr 8.41Cr 7.24Cr 6.81Cr 6.22Cr 12Cr 793.9Cr 12Cr 80Cr 31Cr 407.33Cr 32Cr 31Cr 1.31TCr |
| Net income | 2.38TCr 1.58Cr 1.36Cr 1.28Cr 1.17Cr 2.19Cr 149.38Cr 2.19Cr 15Cr 5.87Cr 77Cr 5.94Cr 5.81Cr 246.91Cr | 308.78Cr 20.49L 17.63L 16.59L 15.15L 28.35L 19Cr 28.42L 1.96Cr 76.06L 9.93Cr 76.94L 75.26L 32Cr |
| Net Debt | 13TCr 8.87Cr 7.63Cr 7.18Cr 6.56Cr 12Cr 837.26Cr 12Cr 85Cr 33Cr 429.57Cr 33Cr 33Cr 1.38TCr | 23TCr 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 21Cr 146.66Cr 57Cr 742.6Cr 58Cr 56Cr 2.39TCr |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | ARS 1,585.00 | +1.60% | 3,631 |
| 03/26/03 | ARS 1,560.00 | -1.58% | 1,635 |
| 02/26/02 | ARS 1,585.00 | +2.26% | 1,189 |
| 01/26/01 | ARS 1,550.00 | -3.73% | 1,659 |
| 31/26/31 | ARS 1,610.00 | +2.55% | 5,467 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















